News about Market

AstraZeneca Plans to Increase Investment and Scope of its Virginia Manufacturing Facility to USD 4.5 Billion

New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines including weight management, metabolic and cancer technologies.<br />

Market | 10/10/2025 | By Dineshwori |  183

Kernal Biologics receives USD 48 Million from ARPA-H

The funding received by Kernal Biologics from ARPA-H is to develop lower cost in vivo CAR T-cell therapies for hematological cancers.

Market | 09/10/2025 | By Dineshwori |  201

Revolutionising Mammography: BPL MedTech Brings LILAC for Faster, Safer Breast Cancer Screening

BPL Medical Technologies is committed to making breast cancer screening a regular part of women’s healthcare by offering LILAC, an advanced digital mammography unit.

Market | 09/10/2025 | By Dineshwori |  179

Rubicon Research to Launch IPO on 9 October; Price Band Set at INR 461- INR 485 Per Share

Rubicon Research Limited has announced the launch of its initial public offering (IPO) of equity shares with a face value of ?1 each, opening on 9 October 2025. The Anchor Investor bidding date is set for 8 October 2025, while the offer will close on 13 October 2025.
<br />

Market | 07/10/2025 | By Darshana |  338

Roche Pharma to Invest 1.5 Billion Swiss Francs in India Over Five Years, Boosting R&D and Access

The funding will be channelled into three critical areas, including research and development, expansion of core businesses, and work with initiatives like Ayushman Bharat to broaden access to innovative products for patients.

Market | 03/10/2025 | By Darshana |  421

Virupaksha Organics Files Draft Papers with SEBI for INR 740 Crore IPO

Virupaksha Organics, an R&D-driven Indian pharmaceutical company specialising in active pharmaceutical ingredients (APIs) and intermediates, has filed draft papers with India’s capital markets regulator, SEBI, to raise INR 740 crore through an initial public offering (IPO).

Market | 01/10/2025 | By Darshana |  226

Testo Saveris to Showcase Comprehensive Pharma Monitoring System at CPHI 2025

Instrumentation and measurement specialist Testo Saveris will present its fully automated and comprehensive monitoring system, testo Saveris 1 at CPHI 2025 in Frankfurt, taking place from 28–30 October.

Market | 01/10/2025 | By Dineshwori |  185

India's Pharma Exports Set to Cross USD 30 Billion by Year-End: Dr Jitendra Singh

India’s pharma exports, currently valued at nearly USD 27.8 billion, are expected to cross USD 30 billion by the end of this year, Union Minister Dr. Jitendra Singh said.

Market | 01/10/2025 | By Dineshwori |  265

Novo Nordisk to Launch Ozempic in India

The once-a-week injectable, Ozempic will complement Novo Nordisk’s existing oral Semaglutide for diabetes and recently approved WeGovy for obesity.

Market | 30/09/2025 | By Dineshwori |  479

GlobalData's AI Tool Predicts Pharmaceutical Drug Approvals with 85 Percent Success Rate

GlobalData’s enhanced AI-powered Likelihood of Approval (LoA) model boosts its predictive power, providing probability of a drug receiving market authorisation.

Market | 29/09/2025 | By Dineshwori |  273